Anti-CIA2A/ CIAO2A/ FAM96A functional antibody

Anti-CIA2A/ CIAO2A/ FAM96A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CIAO2A/CIAO2A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1575-Ab-1/ GM-Tg-hg-SE1575-Ab-2Anti-Human CIAO2A monoclonal antibodyHuman
GM-Tg-rg-SE1575-Ab-1/ GM-Tg-rg-SE1575-Ab-2Anti-Rat CIAO2A monoclonal antibodyRat
GM-Tg-mg-SE1575-Ab-1/ GM-Tg-mg-SE1575-Ab-2Anti-Mouse CIAO2A monoclonal antibodyMouse
GM-Tg-cynog-SE1575-Ab-1/ GM-Tg-cynog-SE1575-Ab-2Anti-Cynomolgus/ Rhesus macaque CIAO2A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1575-Ab-1/ GM-Tg-felg-SE1575-Ab-2Anti-Feline CIAO2A monoclonal antibodyFeline
GM-Tg-cang-SE1575-Ab-1/ GM-Tg-cang-SE1575-Ab-2Anti-Canine CIAO2A monoclonal antibodyCanine
GM-Tg-bovg-SE1575-Ab-1/ GM-Tg-bovg-SE1575-Ab-2Anti-Bovine CIAO2A monoclonal antibodyBovine
GM-Tg-equg-SE1575-Ab-1/ GM-Tg-equg-SE1575-Ab-2Anti-Equine CIAO2A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1575-Ab-1/ GM-Tg-hg-SE1575-Ab-2; GM-Tg-rg-SE1575-Ab-1/ GM-Tg-rg-SE1575-Ab-2;
GM-Tg-mg-SE1575-Ab-1/ GM-Tg-mg-SE1575-Ab-2; GM-Tg-cynog-SE1575-Ab-1/ GM-Tg-cynog-SE1575-Ab-2;
GM-Tg-felg-SE1575-Ab-1/ GM-Tg-felg-SE1575-Ab-2; GM-Tg-cang-SE1575-Ab-1/ GM-Tg-cang-SE1575-Ab-2;
GM-Tg-bovg-SE1575-Ab-1/ GM-Tg-bovg-SE1575-Ab-2; GM-Tg-equg-SE1575-Ab-1/ GM-Tg-equg-SE1575-Ab-2
Products NameAnti-CIAO2A monoclonal antibody
Formatmab
Target NameCIAO2A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CIAO2A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1575-Ag-1Recombinant multi-species CIA2A/ CIAO2A/ FAM96A protein
    ORF Viral VectorpGMLP003413human FAM96A Lentivirus plasmid
    ORF Viral VectorvGMLP003413human FAM96A Lentivirus particle


    Target information

    Target IDGM-SE1575
    Target NameCIAO2A
    Gene ID84191,68250,300797,712029,478335,101089269,512871,100053881
    Gene Symbol and Synonyms5730536A07Rik,CIA2A,CIAO2A,FAM96A,RGD1307481
    Uniprot AccessionQ9H5X1,Q3T0U7
    Uniprot Entry NameCIA2A_HUMAN,CIA2A_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000166797
    Target ClassificationN/A

    The target: CIAO2A, gene name: CIAO2A, also named as CIA2A, FAM96A. Predicted to enable metal ion binding activity. Involved in iron-sulfur cluster assembly and protein maturation by iron-sulfur cluster transfer. Located in cytosol and nucleoplasm. Part of CIA complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.